China adopts a social medical insurance system covering over 95% of the population.

However, out-of-pocket payment accounts for 39.7% of total medical expenses (World Bank 2014) — much higher than developed nations.

Public insurance funds face deficits, and the deficit is estimated to reach RMB 735.3 billion by 2024.

Commercial health insurance covers what public insurance does not: imported drugs, PET-CT, dental implants, organ transplants, etc.

It fills the protection gap and enhances coverage limits (up to RMB 300k from public大病保险 vs millions from private plans).

In 2016, the market penetration of private health insurance reached 9.1% with average annual premium of RMB 3,118 per policy.

The CAGR from 2011 to 2016 was an impressive 42%.

Critical illness and medical supplement products dominate. Personal business premiums are 3.5 times that of group business.

Top 3 players (China Life, Ping An Life, Hexie Health) hold 48% market share — an inverted pyramid structure.

People with monthly income between RMB 6,000-20,000 show the highest TGI for purchasing health insurance.

52% of buyers are ordinary employees, and 76% are married with children.

55% have already bought health insurance for their children — family security is the core driver.

Purchasers are characterized by healthy habits, financial planning (56.7% have regular investment plans), and willingness to pay for quality medical services.

The "tax-advantaged health insurance" policy (annual deduction up to RMB 2,400) changed 42% of previously unwilling respondents to consider buying.

Blockchain, AI, IoT and genetic testing are reshaping the insurance value chain. Precision marketing, dynamic underwriting and automated claims.

Case: "Step-by-Step Insurance" adjusts premiums based on daily steps. "Sugar Baby" for diabetes management rewards healthy blood glucose levels with higher coverage.

Fully digital processes reduce management costs. ZhongAn Insurance + WeDoctor launched direct-billing online outpatient insurance: 60% paid by insurer, medicine delivered to home.

Public hospitals control core medical data but are reluctant to share → crude pricing based on industry-wide morbidity tables.

Value-added services have become key differentiators: overseas treatment, green channels, genetic screening, remote second opinions.

Ping An Health partners with Discovery (Vitality program). Sunshine Insurance owns a general hospital to integrate data. ZhongAn + WeDoctor build an internet healthcare ecosystem.

In 2015, the five specialized health insurers recorded a 10% operating loss (excluding investment income) with claims accounting for 82.6% of health premiums.

Adverse selection and insufficient risk pooling cause high loss ratios.

Group business — lower acquisition cost and risk diversification — delivers better profitability.

Remedy: proactive health management (wearable rewards, disease prevention) to reduce long-term claims.

US private health insurance covers 66% of the population and acts as the dominant payer directing medical resources through managed care networks.

Germany’s statutory health insurance (SHI) covers most citizens, yet private insurers (PHI) thrive through industry associations that negotiate fee schedules with doctors and hospitals, preventing over-treatment.

China could adopt the German approach: build a health insurance industry alliance to gain bargaining power, and promote vertical integration (hospitals, clinics).

Ping An Health: High-end products generate 92% of premium. Multi-tier global medical network + Vitality wellness program.

Sunshine Insurance: Invested in Sunshine Integrative Hospital (>50% stake) to control costs and collect real clinical data.

ZhongAn Insurance: fully online, with "Step-by-Step" and "DuanXiang E-life" (mid-market smash hit). Partnership with WeDoctor for direct-billing online outpatient.

Dtebao: Insurtech broker focusing on pure protection products, using big data for accurate underwriting.

In 2016, the regulator opened applications for specialized health insurer licenses. FOSUN United Health and Ruihua Health obtained licenses.

The "Individual Tax-Preferred Health Insurance暂行办法" guarantees renewability and allows coverage for pre-existing conditions — a game changer.

Survey: 42% of previously unwilling consumers changed their mind due to the tax incentive.

Higher deduction limits would further boost middle-class adoption.

1️⃣ Scenario-based product design: Real-time data (steps, blood glucose) adjusts premiums/coverage dynamically. Increases penetration among niche segments.

2️⃣ Fully digital operations: Online purchase, auto-underwriting, mini-claims reduce management costs and improve customer experience.

3️⃣ Upstream integration: Insurers investing in/in-house hospitals, internet clinics, smart devices — enabling true managed care in China.

AI-driven underwriting and genetic pre-screening will become new moats.

Most satisfied aspects: purchase process (70% highly satisfied) and communication (64%).

Lowest scores: clarity of terms and value-added service relevance.

Differentiated bundles: genetic screening for high-end, remote care for mid-tier, basic health consultation for entry level.

In 2014, China's out-of-pocket health spending was 39.7% of total health expenditure vs. ~10-15% in Germany or UK.

Public insurance + critical illness rider caps at RMB 300k, but advanced cancer therapies cost >500k/year — commercial plans fill the gap.

Upstream: public/private hospitals, internet health firms, pharma/device companies. Midstream: insurers (specialized, life, P&C) and reinsurance. Downstream: individuals, groups, government projects.

Future: integrated "medical-pharmacy-insurance" closed loop.

Current pricing relies on broad industry disease incidence data — insufficient for precision pricing.

Wearables, EHRs, and genomic data will enable personalized premiums and risk control.

Innovative products (e.g., genetic screening based "Long Life 100") break homogeneity. AI medical cost prediction becomes core competence.

China’s private health insurance is taking off — fueled by aging demographics, consumption upgrade, and medical inflation.

The shift from "indemnity for sickness" to "health maintenance" is underway. Insurers must break data silos, enhance service networks, and manage whole-cycle health.

The RMB 1.3 trillion market by 2020 is just the beginning. By 2030, health insurance could surpass auto insurance as the second largest non-life segment.